NCT00586170

Brief Summary

The purpose of this study is to analyze the effect of PEMF in surgical reconstruction of 5th metatarsal non-union fractures.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
8

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2007

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2007

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

December 21, 2007

Completed
14 days until next milestone

First Posted

Study publicly available on registry

January 4, 2008

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2011

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2012

Completed
3.8 years until next milestone

Results Posted

Study results publicly available

May 16, 2016

Completed
Last Updated

June 21, 2017

Status Verified

June 1, 2017

Enrollment Period

3.8 years

First QC Date

December 21, 2007

Results QC Date

March 9, 2016

Last Update Submit

June 19, 2017

Conditions

Keywords

nonunionfracture

Outcome Measures

Primary Outcomes (1)

  • Percentage of Successful 5th Metatarsal Unions Achieved.

    Each patient was assessed radiographically at 2, 4, 6, 8, 12, 16, 20, and 24 weeks or until radiographic signs of healing were evident. The radiographs were evaluated and graded by the number of cortices (medial and lateral on anteroposterior views as well as dorsal and plantar on lateral views) of healing at each time point. Bridging callus across 4 cortices on postoperative radiographs was used to determine healing.

    24 Weeks

Secondary Outcomes (1)

  • Mean AOFAS Score (% Change From Baseline), Foot Function Index (% Change From Baseline), SF-36 Health Survey (Change From Baseline)

    24 Weeks

Study Arms (2)

EBI Bone Healing System + Surgery

EXPERIMENTAL

Subject will be using the EBI Bone Healing System (active device) in conjunction with ORIF surgery of the nonunion site.

Device: EBI Bone Healing SystemProcedure: Surgery

Placebo Device + Surgery

PLACEBO COMPARATOR

Subject will be using a placebo device in conjunction with ORIF surgery of the nonunion site.

Device: Placebo DeviceProcedure: Surgery

Interventions

10 hours of treatment per day for up to 24 weeks

EBI Bone Healing System + Surgery

10 hours of treatment per day for up to 24 weeks

Placebo Device + Surgery
SurgeryPROCEDURE

Open Reduction and Internal Fixation of the nonunion site

EBI Bone Healing System + SurgeryPlacebo Device + Surgery

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subject has been diagnosed with a 5th metatarsal delayed or non-union.
  • Subjects with duration of a 5th metatarsal fracture for a minimum of 3 months.
  • Male or female between ages of 18 and 75 years old, inclusive

You may not qualify if:

  • Subject has synovial pseudarthrosis.
  • Subject has a fracture gap of larger than 5mm as measured on CT Scan.
  • Subjects with conditions associated with elevated circulatory levels of inflammatory cytokines e.g., multiple trauma.
  • If female, subject is pregnant, plans on becoming pregnant during the duration of this clinical outcomes collection study or lactating.
  • Subject has an implanted unipolar pacemaker.
  • Subjects who have previous malignant or connective tissue disorder.
  • Subjects who use medication such as steroids or anticoagulants.
  • Subjects who have an underlying osseous infection (Osteomyelitis) and/or open wound.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Neurological Institute of NJ

Newark, New Jersey, 07103, United States

Location

The Orthopedic Foot and Ankle Center

Columbus, Ohio, 43231, United States

Location

MeSH Terms

Conditions

Fractures, Bone

Interventions

Surgical Procedures, Operative

Condition Hierarchy (Ancestors)

Wounds and Injuries

Results Point of Contact

Title
Manager of Research
Organization
Biomet

Study Officials

  • John Evangelista

    Zimmer Biomet

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 21, 2007

First Posted

January 4, 2008

Study Start

November 1, 2007

Primary Completion

August 1, 2011

Study Completion

August 1, 2012

Last Updated

June 21, 2017

Results First Posted

May 16, 2016

Record last verified: 2017-06

Locations